Fielmann (FIE) Given a €41.00 Price Target at Hauck & Aufhaeuser

Share on StockTwits

Fielmann (FRA:FIE) has been given a €41.00 ($47.67) price objective by equities researchers at Hauck & Aufhaeuser in a report released on Tuesday. The firm currently has a “sell” rating on the stock. Hauck & Aufhaeuser’s price objective would suggest a potential downside of 31.27% from the company’s previous close.

Several other equities research analysts have also recently weighed in on FIE. Oddo Bhf set a €62.00 ($72.09) target price on Fielmann and gave the stock a “buy” rating in a research note on Thursday, October 25th. Kepler Capital Markets set a €50.50 ($58.72) price target on shares of Fielmann and gave the stock a “sell” rating in a report on Tuesday, October 30th. Commerzbank set a €65.00 ($75.58) price target on shares of Fielmann and gave the stock a “neutral” rating in a report on Thursday, November 1st. Baader Bank set a €66.00 ($76.74) price target on shares of Fielmann and gave the stock a “buy” rating in a report on Thursday, November 1st. Finally, equinet set a €55.00 ($63.95) price target on shares of Fielmann and gave the stock a “neutral” rating in a report on Thursday, November 1st. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of €60.04 ($69.82).

FRA FIE opened at €59.65 ($69.36) on Tuesday. Fielmann has a fifty-two week low of €65.50 ($76.16) and a fifty-two week high of €77.50 ($90.12).

About Fielmann

Fielmann Aktiengesellschaft invests in and operates optical and hearing aid businesses in Germany, Switzerland, Austria, and internationally. The company designs, manufactures, distributes, and retails visual aids and other optical products, including glasses, frames, lenses, sunglasses, contact lenses, and related articles and accessories, as well as hearing aids and accessories.

Recommended Story: Options Trading

Analyst Recommendations for Fielmann (FRA:FIE)

Receive News & Ratings for Fielmann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fielmann and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2019 BBNS.